Rhovica Neuroimaging

Company :

Rhovica Neuroimaging

Investment date :

2024

Location :

Bern, Switzerland

Summary

The placement of an external ventricular drain (EVD) is one of the most frequently performed neurosurgical procedures to measure and treat increased brain pressure. The insertion of an EVD catheter, which is often done blindly freehand at the patient’s bedside in the emergency room or intensive care unit to save critical time, regularly requires several attempts. Alternatively, the catheter can be inserted in the operating room with dedicated navigation technology. This dilemma of choosing between speed or accuracy in these critically ill patients contributes to poorer treatment outcomes.

To help neurosurgeons in these situations Rhovica Neuroimaging is developing the innovative SoNav system, which is equipped with integrated sensors for real-time visualization allowing a navigated, safe catheter insertion directly at the bedside. This technology will further enable real-time monitoring of the brain ventricles, reducing the number of risky and costly head-CTs. These innovations will improve neurological outcomes, saving time and lives, while reducing overall healthcare costs.

Neurosurgery is a multi-billion Euro market, with an expected growth rate between 4.5%[1] and 14.2%[2] in the coming years.

[1] Persistence Market Research 2023: Neurosurgery Market

[2] Data Bridge Market Research 2022: Global Neurosurgery Market – Industry Trends and Forecast to 2029

The contribution of M2Care

M2care provides both financial support as well as operational and strategic entrepreneurial expertise, which will accelerate the development of Rhovica Neuroimaging. Together, Rhovica and M2care aim to significantly improve patient care and outcomes in neurosurgery.

Follow us
Contact us

A question? A project?
Our experts answer you